8/1/2013 7:03:19 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
JERSEY CITY, N.J., Aug. 1, 2013 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. OPTR announced today unaudited financial results for the second quarter ended June 30, 2013.
•Second quarter 2013 DIFICID net product sales in the U.S. and Canada of $19.0 million, compared to $15.2 million in the corresponding quarter in 2012, and up 13% from $16.8 million in the first quarter
Help employers find you! Check out all the jobs and post your resume.
comments powered by